CLINICAL_TRIALS
trial_result
· 2021-06-25
Clinical Trial Update: RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY [Phase 2]
Summary
Phase 2 clinical trial update for RT001 in progressive supranuclear palsy (PSP).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biojiva LLC | Conditions: Progressive Supranuclear Palsy | Phase 2 | Status: UNKNOWN